Higher levels of protein hormone associated with lower risk of dementia, Alzheimer's disease

Dec 15, 2009

Persons with higher levels of leptin, a protein hormone produced by fat cells and involved in the regulation of appetite, may have an associated reduced incidence of Alzheimer disease and dementia, according to a study in the December 16 issue of JAMA.

Previous studies have shown that overweight and in mid-life are associated with poorer cognitive function in the general population and an increased risk of . There has been evidence that leptin exerts additional functions on the brain outside the hypothalamus (a region of the brain that controls body temperature, hunger, and thirst), according to background information in the article.

Wolfgang Lieb, M.D., of the Framingham Heart Study, Framingham, Mass., and colleagues examined the relationship between measurements of plasma leptin concentrations and incidence of dementia and Alzheimer disease (AD). For this study, plasma leptin concentrations were measured in 785 persons without dementia (average age, 79 years; 62 percent female), who were in the original Framingham study group at the 22nd examination cycle (1990-1994). A subsample of 198 dementia-free survivors underwent volumetric brain magnetic resonance imaging (MRI) between 1999 and 2005, approximately 7.7 years after leptin was measured. Two measures of were assessed: total cerebral brain volume and temporal horn (a region of the brain) volume, both of which are markers of early AD pathology and subsequent dementia risk. The researchers conducted follow-up for new cases of dementia and AD until Dec. 2007. During a median (midpoint) follow-up of 8.3 years, 111 participants developed dementia; 89 of them were diagnosed with AD.

The researchers found that higher leptin levels were associated with a lower incidence of all-cause dementia and AD. The incidence of decreased gradually across increasing levels of leptin: a person with a baseline leptin level in the lowest quartile group had a 25 percent risk of developing AD after 12 years of follow-up, whereas the corresponding risk for a person in the top quartile group was only 6 percent.

Higher leptin levels were also associated with higher total cerebral brain volume. Lower temporal horn volume was not significantly related to leptin levels.

"These findings are consistent with recent experimental data indicating that leptin improves memory function in animals through direct effects on the hippocampus and strengthens the evidence that leptin is a hormone with a broad set of actions in the central nervous system. Due to the exploratory character of the present analyses, we did not adjust for multiple comparisons and acknowledge that our findings require confirmation in independent samples," the authors write.

"If our findings are confirmed by others, leptin levels in older adults may serve as one of several possible biomarkers for healthy brain aging and, more importantly, may open new pathways for possible preventive and therapeutic intervention. Further exploration of the molecular and cellular basis for the observed association may expand our understanding of the pathophysiology underlying aging and the development of AD."

Explore further: Sierra Leone streets deserted as shutdown begins

More information: JAMA. 2009;302[23]:2565-2572.

add to favorites email to friend print save as pdf

Related Stories

Hunger hormone linked to memory

Jul 20, 2005

Scottish scientists say they've determined the hormone that controls the body's hunger pangs may also boost one's memory.

A link between obesity and memory?

Jun 14, 2006

Scientists have wondered why obese patients who have diabetes also may have problems with their long-term memory. New Saint Louis University research in this month's Peptides provides a clue.

Obesity: Perhaps not all hot fudge sundaes

Apr 10, 2006

University of Pittsburgh scientists say it may not be all hot fudge sundaes and french fries that cause obesity -- it might also be due to brain chemistry.

Recommended for you

Sierra Leone streets deserted as shutdown begins

4 hours ago

Sierra Leone's normally chaotic capital resembled a ghost town on Friday as residents were confined to their homes for the start of a three-day lockdown aimed at halting the deadly Ebola epidemic.

Sierra Leone launches controversial Ebola shutdown

6 hours ago

Sierra Leone on Friday launched a controversial three-day shutdown to contain the deadly spread of the Ebola virus, as the UN Security Council declared the deadly outbreak a threat to world peace.

Cooling of dialysis fluids protects against brain damage

19 hours ago

While dialysis can cause blood pressure changes that damage the brain, cooling dialysis fluids can protect against such effects. The findings come from a study appearing in an upcoming issue of the Journal of the American So ...

Two Ebola vaccines to be tested in Switzerland

19 hours ago

Clinical trials of two experimental vaccines against the deadly Ebola virus are due to begin soon in Switzerland, the country's Tropical and Public Health Institute said on Thursday.

User comments : 0